ENTRY       D00664                      Drug
NAME        Cetirizine hydrochloride (JP18/USP);
            Zyrtec (TN)
PRODUCT     QUZYTTIR (TerSera Therapeutics LLC)
            ZERVIATE (Eyevance Pharmaceuticals)
  GENERIC   ALLERGY RELIEF (Bryant Ranch Prepack)
            CETIRIZINE HYDROCHLORIDE (A-S Medication Solutions)
            CETIRIZINE HYDROCHLORIDE (A-S Medication Solutions)
            CETIRIZINE HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            CETIRIZINE HYDROCHLORIDE (Aventura Pharmaceuticals)
            CETIRIZINE HYDROCHLORIDE (BAJAJ MEDICAL)
            CETIRIZINE HYDROCHLORIDE (Breckenridge Pharmaceutical)
            CETIRIZINE HYDROCHLORIDE (Bryant Ranch Prepack)
            CETIRIZINE HYDROCHLORIDE (Bryant Ranch Prepack)
            CETIRIZINE HYDROCHLORIDE (DIRECT RX)
            CETIRIZINE HYDROCHLORIDE (Lannett Company)
            CETIRIZINE HYDROCHLORIDE (Padagis Israel Pharmaceuticals)
            CETIRIZINE HYDROCHLORIDE (Preferred Pharmaceuticals)
            CETIRIZINE HYDROCHLORIDE (Proficient Rx LP)
            CETIRIZINE HYDROCHLORIDE (Proficient Rx LP)
            CETIRIZINE HYDROCHLORIDE (Taro Pharmaceuticals U.S.A.)
            CETIRIZINE HYDROCHLORIDE ORAL SOLUTION (Chartwell RX)
FORMULA     C21H25ClN2O3. 2HCl
EXACT_MASS  460.1087
MOL_WEIGHT  461.8097
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Transporter substrate
             DG01665  ABCB1 substrate
             DG02854  SLC22A2 substrate
            Transporter inhibitor
             DG02863  SLC22A2 inhibitor
REMARK      Therapeutic category: 4490
            ATC code: R06AE07 S01GX12
            Chemical structure group: DG01107
            Product (DG01107): D00664<JP/US>
EFFICACY    Antiallergic, H1 receptor antagonist
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction
            hsa04750(3269)  Inflammatory mediator regulation of TRP channels
METABOLISM  Transporter: ABCB1 [HSA:5243], SLC22A2 [HSA:6582]
INTERACTION Transporter inhibition: SLC22A2 [HSA:6582]
STR_MAP     map07212  Histamine H1 receptor antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R06 ANTIHISTAMINES FOR SYSTEMIC USE
               R06A ANTIHISTAMINES FOR SYSTEMIC USE
                R06AE Piperazine derivatives
                 R06AE07 Cetirizine
                  D00664  Cetirizine hydrochloride (JP18/USP) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01G DECONGESTANTS AND ANTIALLERGICS
                S01GX Other antiallergics
                 S01GX12 Cetirizine
                  D00664  Cetirizine hydrochloride (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Ophthalmic Anti-Allergy Agents
               Antihistamine
                Cetirizine
                 D00664  Cetirizine hydrochloride (JP18/USP)
             Respiratory Tract/Pulmonary Agents
              Antihistamines
               Histamine (H1) Receptor Antagonists, Mildly/Non-sedating
                Cetirizine
                 D00664  Cetirizine hydrochloride (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              44  Allergic agents
               449  Miscellaneous
                4490  Miscellaneous
                 D00664  Cetirizine hydrochloride (JP18/USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for otolaryngologic use
              69 Oral medicine for nasal inflammation
               D00664  Cetirizine hydrochloride (JP18/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Second-class OTC drugs
              Inorganic and organic chemicals
               Cetirizine
                D00664  Cetirizine hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG01107  Cetirizine
                 D00664  Cetirizine hydrochloride
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00664  Cetirizine hydrochloride
             Transporter substrate
              DG01665  ABCB1 substrate
               DG01107  Cetirizine
                D00664  Cetirizine hydrochloride
              DG02854  SLC22A2 substrate
               DG01107  Cetirizine
                D00664  Cetirizine hydrochloride
             Transporter inhibitor
              DG02863  SLC22A2 inhibitor
               DG01107  Cetirizine
                D00664  Cetirizine hydrochloride
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D00664  Cetirizine hydrochloride
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00664  Cetirizine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D00664  Cetirizine hydrochloride (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00664  Cetirizine hydrochloride
              D00664  Cetirizine hydrochloride tablets
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D00664
            Rx-to-OTC switch list in the USA [br08315.html]
             D00664
            Rx-to-OTC switch list in Japan [br08314.html]
             D00664
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG01107  Cetirizine
             Transporter substrate
              DG01665  ABCB1 substrate
               DG01107  Cetirizine
              DG02854  SLC22A2 substrate
               DG01107  Cetirizine
             Transporter inhibitor
              DG02863  SLC22A2 inhibitor
               DG01107  Cetirizine
DBLINKS     CAS: 83881-52-1
            PubChem: 7847730
            ChEBI: 3562
            LigandBox: D00664
            NIKKAJI: J561.977G
ATOM        29
            1   C8x C    22.3396  -18.4537
            2   C8y C    22.3396  -19.8566
            3   C8x C    23.5544  -20.5580
            4   C8x C    24.7694  -19.8566
            5   C8y C    24.7694  -18.4537
            6   C8x C    23.5544  -17.7523
            7   C8x C    27.1992  -19.8566
            8   C8y C    27.1992  -18.4537
            9   C1c C    25.9843  -17.7523
            10  C8x C    28.4141  -20.5580
            11  C8x C    29.6290  -19.8566
            12  C8x C    29.6290  -18.4537
            13  C8x C    28.4141  -17.7523
            14  N1y N    25.9843  -16.3494
            15  C1x C    27.2013  -15.6468
            16  C1x C    27.2013  -14.2439
            17  N1y N    25.9863  -13.5425
            18  C1x C    24.7694  -14.2451
            19  C1x C    24.7694  -15.6480
            20  X   Cl   21.1247  -20.5580
            21  C1b C    25.9863  -12.1408
            22  C1b C    27.2018  -11.4391
            23  O2a O    28.3999  -12.1310
            24  C1b C    29.5895  -11.4443
            25  C6a C    30.7833  -12.1337
            26  O6a O    31.9752  -11.4456
            27  O6a O    30.7833  -13.5434
            28  X   Cl   31.6686  -16.0688
            29  X   Cl   31.6686  -16.0688
BOND        29
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     7   8 1
            8     8   9 1
            9     5   9 1
            10    7  10 2
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14    8  13 2
            15    9  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 1
            19   17  18 1
            20   18  19 1
            21   14  19 1
            22    2  20 1
            23   17  21 1
            24   21  22 1
            25   22  23 1
            26   23  24 1
            27   24  25 1
            28   25  26 1
            29   25  27 2
BRACKET     1    30.2400  -16.8000   30.2400  -15.2600
            1    32.3400  -15.2600   32.3400  -16.8000
            1  2
  ORIGINAL  1   28
  REPEAT    1   29
///
